LAG3 and lung cancer: Of note, PD1 expression was lower than LAG3 and TIGIT in CD8+ T cells (Supplementary Fig. S2b), suggesting that LAG3 and TIGIT might be potential targets for alternative immunotherapies in lung cancer CNSm.